Besides CRP, novel biomarkers like matrix metalloproteinases (MMPs) 3,7, and 9 and the tissue inhibitors of metalloproteinase (TIMP)-1 are elevated in those with carotid atherosclerosis, and the elevation of those biomarkers parallel with the percentage of carotid artery stenosis. This evidence concerns the gene CRP and coronary atherosclerosis measurement.